Corporate news
Grifols Announces Winner of the 2018 SPIN Award for Immunoglobulin Research in Neurology at the 2018 Peripheral Nerve Society Annual Meeting The 2018 SPIN Award was presented to Miriam Fichtner, from Yale University, to support her research project "IVIg influence on pathogenic B cells in myasthenia gravis"
+ info
+ info
Procleix® Zika Virus Assay Approved by the FDA for Blood Screening on the Procleix® Panther® System Procleix Zika Virus assay provides U.S. blood banks the ability to screen blood donations for the presence of the Zika virus and improve blood transfusion safety
+ info
+ info
Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins Grifols' investment opens up growth opportunities in contract development and manufacturing services to current and future customers.
+ info
+ info
Highlights
Manufacturing
We are a solid company with an international dimension.
Corporate Commitment
We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.
When a Dream Comes True. An Illustrated History of 75 Years of Grifols
Read When a Dream Comes True: An illustrated history of 75 years of Grifols to discover the company's roots, and learn more about our history and the development of the company. + info